Publication

Retroperitoneal lymph node dissection: the past, present, and future, a review

Jun 30, 2023 · 4 authors · 3 topics

Abstract

Testicular cancer is a malignancy that impacts young men worldwide. The modern treatment of testicular cancer has evolved due to innovations in medical approaches and surgical techniques. The retroperitoneal lymph node dissection (RPLND) is an integral component in the treatment of testicular cancer. We aim to highlight the advances in surgical approaches and oncologic considerations noted over the past century. Once recognized as a highly morbid procedure, innovations in the under standing of anatomy and minimally invasive approaches have greatly improved patient outcomes. In addition to surgical approaches, we describe oncologic prin ciples associated with modern dissection templates for both non-seminomatous germ cell tumors as well as more recent indications for surgery in seminomatous germ cell tumors. The overall goal of this review is to provide a summary in the utility and recent advances in RPLND techniques. Insight Urol 2023;44(1):43-50. doi: 10.52786/isu.a.71 Keywords: Testicular cancer, retroperitoneal lymph node dissection, modified template, nerve-sparing

Showing the abstract — retrieve the full paper via the Exa API.

Authors

Shyam PatnaikJohn M. MyrgaRobin V. VasanTatum V. Tarin

Topics

Testicular diseases and treatmentsSarcoma Diagnosis and TreatmentUPMC Department of Urology, Pittsburgh, PA, USA

About

PublishedJun 30, 2023
TypeArticle
Citations0
References23

Powered by the Exa API